Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine, Ahead of Print.
Source: New England Journal of Medicine - Category: Internal Medicine Authors: Stephen D. Wiviott Itamar Raz Marc P. Bonaca Ofri Mosenzon Eri T. Kato Avivit Cahn Michael G. Silverman Thomas A. Zelniker Julia F. Kuder Sabina A. Murphy Deepak L. Bhatt Lawrence A. Leiter Darren K. McGuire John P.H. Wilding Christian T. Ruff Ingrid A.M. Source Type: research
More News: Cardiology | Cardiovascular | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Heart | Internal Medicine | Legislation